Maddy summaryThis bill adds the drug tianeptine to North Carolina's list of Schedule II controlled substances, meaning it will be regulated similarly to other opioids. By making this change, the law aims to increase oversight of the drug, which is already associated with potential for abuse and severe dependence. The new rules will apply to anyone who commits offenses involving tianeptine on or after September 1, 2024.
Rep. Renée Price
Sponsored bills
Maddy summaryHB 1042 establishes a reimbursement program in North Carolina to help cover veterinary expenses for retired law enforcement and correctional dogs. To qualify, the dogs must have served in official capacities such as detection, apprehension, or search and rescue and hold certification from a national organization. Owners can apply for up to $1,500 annually for essential care like check-ups, vaccinations, emergency surgeries, and euthanasia, but not for elective procedures. The Department of Public Safety will manage a dedicated fund, initially seeded with $300,000, to process these claims and maintain records. The law applies to dogs retiring on or after July 1, 2024, and allows owners to participate voluntarily without affecting any other existing benefits.
Maddy summaryThis bill directs the North Carolina Policy Collaboratory to conduct a study on how proposed changes to the county tier designation system would affect the state's 100 counties. The study will examine potential adjustments to the criteria for ranking counties, the method used to assign tiers, and the timeline for these rankings. It will also assess how these changes impact state programs, business operations, and the accuracy of identifying distressed areas using current data. Funded with $100,000, the Collaboratory must submit a preliminary report by December 31, 2024, and a final report by December 1, 2025, to legislative oversight committees.
Maddy summaryHB 935 reorganizes the Advisory Council on Rare Diseases in North Carolina by moving it from the University of North Carolina at Chapel Hill to the Department of Health and Human Services. The bill establishes a 19-member council composed of physicians, researchers, patient advocates, industry representatives, and other stakeholders to advise state leaders on rare disease research, diagnosis, treatment, and education. Key provisions include setting specific term lengths for members, providing administrative support and funding for the council's operations, and requiring annual reports on council activities and recommendations.